| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.02 | 0.9 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | 0.015 | 0.9 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | 0.018 | 0.9 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.013 | 0.9 |